Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 2

Evaluation of cardiovascular autonomic dysfunction according to heart rate turbulence and variability in patients with relapsing remitting multiple sclerosis

Pages
442–447
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Magnetic resonance imaging findings werereevaluated to identify any demyelinating lesions in the brain stem.Results: The HRV parameters of SDNNI (mean of the standard deviations of all normal sinus RR intervals in all 5-min segments),rMSSD (root–mean–square successive difference), and sNN50 (percentage of successive normal sinus RR intervals >50 ms) weresignificantly lower in the MS group than in the control group (P < 0.05).Conclusion: This study revealed that the patients with MS had reduced HRV; this was demonstrated by dysfunction with regard toparasympathetic and sympathetic parameters in HRV analysis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Multiple sclerosis (MS) is an autoimmune disease characterized by neurodegeneration or demyelination; therelapsing–remitting phase of MS is characterized by acute exacerbation of disease activity.
📊
Key Findings & Data:The most commonly used noninvasiveapproach to assess autonomic function is the determination of heart rate turbulence (HRT) and heart rate variability (HRV).
💡
Conclusion & Impact:Magnetic resonance imaging findings werereevaluated to identify any demyelinating lesions in the brain stem.Results: The HRV parameters of SDNNI (mean of the standard deviations of all normal sinus RR intervals in all 5-min segments),rMSSD (root–mean–square successive difference), and sNN50 (percentage of successive normal sinus RR intervals >50 ms) weresignificantly lower in the MS group than in the control group (P < 0.05).Conclusion: This study revealed that the patients with MS had reduced HRV; this was demonstrated by dysfunction with regard toparasympathetic and sympathetic parameters in HRV analysis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Multiple sclerosis (MS) is an autoimmune disease characterized by neurodegeneration or demyelination; therelapsing–remitting phase of MS is characterized by acute exacerbation of disease activity. The most commonly used noninvasiveapproach to assess autonomic function is the determination of heart rate turbulence (HRT) and heart rate variability (HRV). The aim ofthis study was to evaluate the presence of cardiovascular autonomic dysfunction using HRT and HRV parameters determined via 24-hHolter ECG monitoring in patients with relapsing–remitting MS without known heart disease.Materials and methods: The study included 26 patients diagnosed with relapsing–remitting MS and 22 age- and sex-matched healthycontrols. HRT and HRV parameters were analyzed via 24-h Holter ECG monitoring. Magnetic resonance imaging findings werereevaluated to identify any demyelinating lesions in the brain stem.Results: The HRV parameters of SDNNI (mean of the standard deviations of all normal sinus RR intervals in all 5-min segments),rMSSD (root–mean–square successive difference), and sNN50 (percentage of successive normal sinus RR intervals >50 ms) weresignificantly lower in the MS group than in the control group (P < 0.05).Conclusion: This study revealed that the patients with MS had reduced HRV; this was demonstrated by dysfunction with regard toparasympathetic and sympathetic parameters in HRV analysis.

🔖

Cite This Article

GÖKASLAN, S., GÖKASLAN, Ç. Ö., DEMİRBAŞ, H. (2022). Evaluation of cardiovascular autonomic dysfunction according to heart rate turbulence and variability in patients with relapsing remitting multiple sclerosis. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 2, 442–447. https://ajindex.com/articles/609652

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Compston, A, Coles A. Multiple sclerosis. Lancet 2008; 372(9648): 1502-1517
  2. Wu, GF, Alvarez E. The immunopathophysiology of multiple sclerosis. Neurologic Clinics 2011; 29 (2): 257-278
  3. Murray CJL, Lopez A. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston, MA, USA: Harvard School of Public Health; 1996. pp. 1-98
  4. Bsteh G, Ehling R, Lutterotti A, Hegen H, Di Pauli F et al. Long term clinical prognostic factors in relapsing-remitting multiple sclerosis: insights from a 10-year observational study. PLoS One 2016; 11 (7): e0158978
  5. Adamec I, Habek M. Autonomic dysfunction in multiple sclerosis. Clinical Neurology and Neurosurgery 2013; 115 Suppl 1: 73-78
  6. Saari A, Tolonen U, Pääkkö E, Suominen K, Pyhtinen J et al. Cardiovascular autonomic dysfunction correlates with brain MRI lesion load in MS. Clinical Neurophysiology 2004; 115 (6): 1473-1478
  7. Polak, PE, Kalinin S, Feinstein DL. Locus coeruleus damage and noradrenaline reductions in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain 2011; 134 (Pt 3): 665-677
  8. Crnošija L, Adamec I, Lovrić M, Junaković A, Krbot Skorić M et al. Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis. Clinical Neurophysiology 2016; 127 (1): 864-869
  9. Zuern, CS, Barthel P, Bauer A. Heart rate turbulence as riskpredictor after myocardial infarction. Frontiers in Physiology 2011; 2: 99
  10. Cygankiewicz I. Heart rate turbulence. Progress in Cardiovascular Diseases 2013; 56 (2): 160-171
  11. La Rovere MT, Maestri R, Pinna GD, Sleight P, Febo O. Clinical and haemodynamic correlates of heart rate turbulence as a non-invasive index of baroreflex sensitivity in chronic heart failure. Clinical Science 2011; 121 (6): 279-284
  12. D’Addio G, Cesarelli M, Corbi G, Romano M, Furgi G et al. Reproducibility of heart rate turbulence indexes in heart failure patients. IEEE Engineering in Medicine and Biology Society 2010: 2573-2576
  13. Thanou A, Stavrakis S, Dyer JW, Munroe ME, James JA et al. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity. Arthritis Research and Therapy 2016; 18: 197
  14. Billman GE, Huikuri HV, Sacha J, Trimmel K et al. An introduction to heart rate variability: methodological considerations and clinical applications. Frontiers in Physiology 2015; 6: 55
  15. McDonald WI, Compston A, Edan G, Goo